Search

Your search keyword '"Violette, Philippe D."' showing total 292 results
Start Over Author "Violette, Philippe D."
292 results on '"Violette, Philippe D."'

1. Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes

Author

Leong, Darryl P., Fradet, Vincent, Niazi, Tamim, Selvanayagam, Joseph B., Sabbagh, Robert, Higano, Celestia S., Agapay, Steven, Rangarajan, Sumathy, Mian, Rajibul, Nakashima, Carlos A.K., Mousavi, Negareh, Brown, Ian, Valle, Felipe H., Lavallée, Luke T., Shayegan, Bobby, Ng, Kelvin K.H., Gopaul, Darin D., Cavalli, Germano D., Saavedra, Sonia, Lopez-Lopez, Jose P., Freitas de Souza, Cristiano, Duceppe, Emmanuelle, Avezum Oliveira, Lívia F., Guha, Avirup, Gomez-Mesa, Juan Esteban, Eduardo Silva Móz, Luis, Violette, Philippe D., Avezum, Álvaro, Oliveira, Gustavo B.F., Kann, Ariel G., Walter, Edilson, Dusilek, Cesar O.L., Villareal Trujillo, Nicolas, Beato, Patricia, Hajjar, Ludhmila A., Luke, Patrick P.W., Schlabendorff, Eduardo, Sarid, David, and Pinthus, Jehonathan

Published
2024
Full Text
View/download PDF

2. Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis

Author

Ahopelto, Kaisa, Aoki, Yoshitaka, Beilmann-Lehtonen, Ines, Blanker, Marco H., Craigie, Samantha, Elberkennou, Jaana, Garcia-Perdomo, Herney A., Gomaa, Huda A., Gross, BCPS; Peter, Hajebrahimi, Sakineh, Huang, Linglong, Karanicolas, Paul J., Kilpeläinen, Tuomas P., Kivelä, Antti J., Korhonen, Tapio, Lampela, Hanna, Lee, Yung, Mattila, Anne K., Najafabadi, Borna Tadayon, Nykänen, Taina P., Nystén, Carolina, Pandanaboyana, Sanjay, Ratnayake, Chathura B.B., Raudasoja, Aleksi R., Sallinen, Ville J., Violette, Philippe D., Xiao, Yingqi, Yao, Liang, Lavikainen, Lauri I., Guyatt, Gordon H., Kalliala, Ilkka E.J., Cartwright, Rufus, Luomaranta, Anna L., Vernooij, Robin W.M., Tähtinen, Riikka M., Tadayon Najafabadi, Borna, Singh, Tino, Pourjamal, Negar, Oksjoki, Sanna M., Khamani, Nadina, Karjalainen, Päivi K., Joronen, Kirsi M., Izett-Kay, Matthew L., Haukka, Jari, Halme, Alex L.E., Ge, Fang Zhou, Galambosi, Päivi J., Devereaux, P.J., Cárdenas, Jovita L., Couban, Rachel J., Aro, Karoliina M., Aaltonen, Riikka L., and Tikkinen, Kari A.O.

Published
2024
Full Text
View/download PDF

3. Risk of thrombosis and bleeding in gynecologic cancer surgery: systematic review and meta-analysis

Author

Ahopelto, Kaisa, Aoki, Yoshitaka, Beilmann-Lehtonen, Ines, Blanker, Marco H., Craigie, Samantha, Elberkennou, Jaana, Garcia-Perdomo, Herney A., Gomaa, Huda A., Gross, Peter, Hajebrahimi, Sakineh, Karanicolas, Paul J., Kilpeläinen, Tuomas P., Kivelä, Antti J., Korhonen, Tapio, Lampela, Hanna, Lee, Yung, Mattila, Anne K., Najafabadi, Borna Tadayon, Nykänen, Taina P., Nystén, Carolina, Pandanaboyana, Sanjay, Ratnayake, Chathura B.B., Raudasoja, Aleksi R., Sallinen, Ville J., Violette, Philippe D., Xiao, Yingqi, Yao, Liang, Lavikainen, Lauri I., Guyatt, Gordon H., Luomaranta, Anna L., Cartwright, Rufus, Kalliala, Ilkka E.J., Couban, Rachel J., Aaltonen, Riikka L., Aro, Karoliina M., Cárdenas, Jovita L., Devereaux, P.J., Galambosi, Päivi J., Ge, Fang Zhou, Halme, Alex L.E., Haukka, Jari, Izett-Kay, Matthew L., Joronen, Kirsi M., Karjalainen, Päivi K., Khamani, Nadina, Oksjoki, Sanna M., Pourjamal, Negar, Singh, Tino, Tähtinen, Riikka M., Vernooij, Robin W.M., and Tikkinen, Kari A.O.

Published
2024
Full Text
View/download PDF

4. Reporting of costs and economic impacts in randomized trials of de-implementation interventions for low-value care: a systematic scoping review

Author

Falkenbach, Petra, Raudasoja, Aleksi J., Vernooij, Robin W. M., Mustonen, Jussi M. J., Agarwal, Arnav, Aoki, Yoshitaka, Blanker, Marco H., Cartwright, Rufus, Garcia-Perdomo, Herney A., Kilpeläinen, Tuomas P., Lainiala, Olli, Lamberg, Tiina, Nevalainen, Olli P. O., Raittio, Eero, Richard, Patrick O., Violette, Philippe D., Tikkinen, Kari A. O., Sipilä, Raija, Turpeinen, Miia, and Komulainen, Jorma

Published
2023
Full Text
View/download PDF

5. Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery

Author

Lavikainen, Lauri I., Guyatt, Gordon H., Sallinen, Ville J., Karanicolas, Paul J., Couban, Rachel J., Singh, Tino, Lee, Yung, Elberkennou, Jaana, Aaltonen, Riikka, Ahopelto, Kaisa, Beilmann-Lehtonen, Ines, Blanker, Marco H., Cárdenas, Jovita L., Cartwright, Rufus, Craigie, Samantha, Devereaux, P.J., Garcia-Perdomo, Herney A., Ge, Fang Zhou, Gomaa, Huda A., Halme, Alex L.E., Haukka, Jari, Karjalainen, Päivi K., Kilpeläinen, Tuomas P., Kivelä, Antti J., Lampela, Hanna, Mattila, Anne K., Najafabadi, Borna Tadayon, Nykänen, Taina P., Pandanaboyana, Sanjay, Pourjamal, Negar, Ratnayake, Chathura B.B., Raudasoja, Aleksi, Vernooij, Robin W.M., Violette, Philippe D., Wang, Yuting, Xiao, Yingqi, Yao, Liang, Tikkinen, Kari A. O., Aoki, Yoshitaka, Aro, Karoliina M., Galambosi, Päivi J., Gross, Peter, Hajebrahimi, Sakineh, Huang, Linglong, Izett-Kay, Matthew L., Joronen, Kirsi M., Kalliala, Ilkka E.J., Khamani, Nadina, Korhonen, Tapio, Luomaranta, Anna L., Nystén, Carolina, Oksjoki, Sanna M., and Tähtinen, Riikka M.

Published
2024
Full Text
View/download PDF

9. The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer: A RADICAL-PC Analysis

Author

Klimis, Harry, Pinthus, Jehonathan H., Aghel, Nazanin, Duceppe, Emmanuelle, Fradet, Vincent, Brown, Ian, Siemens, D. Robert, Shayegan, Bobby, Klotz, Laurence, Luke, Patrick P., Niazi, Tamim, Lavallee, Luke T., Mousavi, Negareh, Hamilton, Robert J., Chin, Joseph L., Gopaul, Darin, Violette, Philippe D., Davis, Margot K., Hanna, Nawar, Sabbagh, Robert, Ben Zadok, Osnat Itzhaki, Hajjar, Ludhmila Abrahão, Kann, Ariel Galapo, Mian, Rajibul, Rangarajan, Sumathy, Huei Ng, Kelvin Kuan, Iakobishvili, Zaza, Selvanayagam, Joseph B., Avezum, Alvaro, and Leong, Darryl P.

Published
2023
Full Text
View/download PDF

13. Randomized controlled trials in de-implementation research: a systematic scoping review

Author

Raudasoja, Aleksi J., Falkenbach, Petra, Vernooij, Robin W. M., Mustonen, Jussi M. J., Agarwal, Arnav, Aoki, Yoshitaka, Blanker, Marco H., Cartwright, Rufus, Garcia-Perdomo, Herney A., Kilpeläinen, Tuomas P., Lainiala, Olli, Lamberg, Tiina, Nevalainen, Olli P. O., Raittio, Eero, Richard, Patrick O., Violette, Philippe D., Komulainen, Jorma, Sipilä, Raija, and Tikkinen, Kari A. O.

Published
2022
Full Text
View/download PDF

14. MP51-16 FIVE-YEAR MORTALITY AND ONCOLOGIC OUTCOMES IN SMALL RENAL MASSES PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Author

Kandi, Maryam, primary, Richard, Patrick O., additional, Violette, Philippe D., additional, Sreekanta, Ashwini, additional, Couban, Rachel, additional, Diaz, Clara, additional, Morin, Alexandre, additional, McNeil-Gauthier, Anne-Lou, additional, Thivierge-Abel, Rose, additional, Joseph, Junon, additional, Charbonneau, Genevieve, additional, and Guyatt, Gordon, additional

Published
2024
Full Text
View/download PDF

15. Endoscopic Incisions

Author

Bjazevic, Jennifer, Violette, Philippe D., Razvi, Hassan, Best, Sara L., editor, and Nakada, Stephen Y., editor

Published
2020
Full Text
View/download PDF

17. Systematic Reviews and Meta-Analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery

Author

MS Nefrologie, Lavikainen, Lauri I., Guyatt, Gordon H., Sallinen, Ville J., Karanicolas, Paul J., Couban, Rachel J., Singh, Tino, Lee, Yung, Elberkennou, Jaana, Aaltonen, Riikka, Ahopelto, Kaisa, Beilmann-Lehtonen, Ines, Blanker, Marco H., Cárdenas, Jovita L., Cartwright, Rufus, Craigie, Samantha, Devereaux, P. J., Garcia-Perdomo, Herney A., Ge, Fang Zhou, Gomaa, Huda A., Halme, Alex L.E., Haukka, Jari, Karjalainen, Päivi K., Kilpeläinen, Tuomas P., Kivelä, Antti J., Lampela, Hanna, Mattila, Anne K., Najafabadi, Borna Tadayon, Nykänen, Taina P., Pandanaboyana, Sanjay, Pourjamal, Negar, Ratnayake, Chathura B.B., Raudasoja, Aleksi, Vernooij, Robin W.M., Violette, Philippe D., Wang, Yuting, Xiao, Yingqi, Yao, Liang, Tikkinen, Kari A.O., MS Nefrologie, Lavikainen, Lauri I., Guyatt, Gordon H., Sallinen, Ville J., Karanicolas, Paul J., Couban, Rachel J., Singh, Tino, Lee, Yung, Elberkennou, Jaana, Aaltonen, Riikka, Ahopelto, Kaisa, Beilmann-Lehtonen, Ines, Blanker, Marco H., Cárdenas, Jovita L., Cartwright, Rufus, Craigie, Samantha, Devereaux, P. J., Garcia-Perdomo, Herney A., Ge, Fang Zhou, Gomaa, Huda A., Halme, Alex L.E., Haukka, Jari, Karjalainen, Päivi K., Kilpeläinen, Tuomas P., Kivelä, Antti J., Lampela, Hanna, Mattila, Anne K., Najafabadi, Borna Tadayon, Nykänen, Taina P., Pandanaboyana, Sanjay, Pourjamal, Negar, Ratnayake, Chathura B.B., Raudasoja, Aleksi, Vernooij, Robin W.M., Violette, Philippe D., Wang, Yuting, Xiao, Yingqi, Yao, Liang, and Tikkinen, Kari A.O.

Published
2024

18. Thromboprophylaxis practice patterns and beliefs among physicians treating patients with abdominopelvic cancers at a Canadian centre

Author

McAlpine, Kristen, Breau, Rodney H., Carrier, Marc, Violette, Philippe D., Knee, Christopher, Cagiannos, Ilias, Morash, Christopher, and Lavallee, Luke T.

Subjects
Pelvic cancer -- Development and progression -- Care and treatment, Abdominal cancer -- Development and progression -- Care and treatment, Health, Health care industry
Abstract

Background: There is inadequate high-quality evidence on thromboprophylaxis for patients undergoing surgery for abdominopelvic cancer. We surveyed physicians who treat patients with abdominopelvic cancer to determine current thromboprophylaxis practice patterns and to determine where research is needed. Methods: We created an online survey with questions on thromboprophylaxis topics, including type of thromboprophylaxis used, timing of initial thromboprophylaxis dose, use of thromboprophylaxis during chemotherapy, use of extended-duration thromboprophylaxis and areas for future research. The survey questions were reviewed by external content experts to ensure they were appropriate and relevant. Surgeons, thrombosis experts and medical oncologists who manage patients with abdominopelvic cancers at 1 large Canadian academic centre were invited to complete the survey between January and April 2019. Results: Of the 57 physicians invited, 42 (74%) completed the survey, including 27 surgeons (response rate 79%), 9 thrombosis experts (response rate 75%) and 6 medical oncologists (response rate 55%). Most surgeons (22 [82%]) reported using mechanical thromboprophylaxis, whereas only 1 thrombosis expert (11%) recommended mechanical thromboprophylaxis. There was substantial variability in the timing of the initial dose of thromboprophylaxis, with 9/10 urologists (90%) and all 7 general surgeons giving the first dose intraoperatively, and three-quarters of thoracic surgeons (3/4 [75%]), gynecologists (3/4 [75%]) and thrombosis experts (7/9 [78%]) starting thromboprophylaxis after surgery. All medical oncologists believed chemotherapy increases the risk of venous thromboembolism, but 4 (67%) reported that they do not routinely prescribe thromboprophylaxis owing to bleeding concerns. Most respondents (35/38 [92%]) felt there was a need for more research on thromboprophylaxis and indicated willingness to participate in future clinical trials. Conclusion: Variability exists in contemporary thromboprophylaxis practice patterns among physicians treating patients with abdominopelvic cancer. Future research is needed to standardize care and improve outcomes for patients. Contexte : On manque de donnees de qualite elevee sur la thromboprophylaxie chez les patients traites en chirurgie pour un cancer abdomino-pelvien. Nous avons sonde des medecins traitant ces patients afin de determiner les tendances actuelles relatives a cette pratique et pour cerner les besoins en recherche. Methodes : Nous avons cree un sondage en ligne sur la thromboprophylaxie, comprenant des questions sur le type utilise, le moment d'administration de la dose initiale, le recours durant la chimiotherapie, l'utilisation prolongee et les domaines de recherche a explorer. Les questions ont ete validees par des experts de contenu externes, qui ont veille a ce qu'elles soient appropriees et pertinentes. Des chirurgiens, des experts en thrombose et des oncologues qui s'occupent de patients atteints de cancers abdomino-pelviens dans un grand centre hospitalier universitaire canadien ont ete invites a remplir le sondage entrer janvier et avril 2019. Resultats : Des 57 medecins sollicites, 42 (74 %) ont repondu au sondage, dont 27 chirurgiens (taux de reponse de 79 %), 9 experts en thrombose (taux de reponse de 75 %) et 6 oncologues (taux de reponse de 55 %). La majorite des chirurgiens (22 [82 %]) recouraient a la thromboprophylaxie mecanique, alors qu'un seul expert en thrombose (11 %) recommandait cette pratique. Le moment d'administration de la dose initiale variait considerablement : 9 urologues sur 10 (90 %) et chacun des 7 chirurgiens generalistes administraient la premiere dose durant l'operation, alors que les trois quarts des chirurgiens thoraciques (3/4 [75 %]), des gynecologues (3/4 [75 %]) et des experts en thrombose (7/9 [78 %]) commencaient la thromboprophylaxie apres l'intervention. Tous les oncologues etaient d'avis que la chimiotherapie augmentait le risque de thromboembolie veineuse, mais 4 (67 %) ont indique qu'ils ne prescrivaient pas d'emblee de thromboprophylaxie en raison des risques de saignements. La plupart des repondants (35/38 [92 %]) consideraient qu'il faudrait etudier davantage la thromboprophylaxie et ont indique leur volonte de participer a d'eventuels essais cliniques. Conclusion : A l'heure actuelle, les pratiques liees a la thromboprophylaxie varient chez les medecins traitant des patients atteints de cancers abdomino-pelviens. Il fau-dra mener d'autres etudes pour normaliser la prestation des soins et ameliorer les resultats pour les patients., Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, is the leading cause of noncancer death among patients who undergo surgery for cancer. (1) Even when patients survive [...]

Published
2020
Full Text
View/download PDF

20. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

Author

Lam, Thomas B.L., MacLennan, Steven, Willemse, Peter-Paul M., Mason, Malcolm D., Plass, Karin, Shepherd, Robert, Baanders, Ruud, Bangma, Chris H., Bjartell, Anders, Bossi, Alberto, Briers, Erik, Briganti, Alberto, Buddingh, Karel T., Catto, James W.F., Colecchia, Maurizio, Cox, Brett W., Cumberbatch, Marcus G., Davies, Jeff, Davis, Niall F., De Santis, Maria, Dell’Oglio, Paolo, Deschamps, André, Donaldson, James F., Egawa, Shin, Fankhauser, Christian D., Fanti, Stefano, Fossati, Nicola, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Gross, Tobias, Grummet, Jeremy P., Henry, Ann M., Ingels, Alexandre, Irani, Jacques, Lardas, Michael, Liew, Matthew, Lin, Daniel W., Moris, Lisa, Omar, Muhammad Imran, Pang, Karl H., Paterson, Catherine C., Renard-Penna, Raphaële, Ribal, Maria J., Roobol, Monique J., Rouprêt, Morgan, Rouvière, Olivier, Sancho Pardo, Gemma, Richenberg, Jonathan, Schoots, Ivo G., Sedelaar, J.P. Michiel, Stricker, Phillip, Tilki, Derya, Vahr Lauridsen, Susanne, van den Bergh, Roderick C.N., Van den Broeck, Thomas, van der Kwast, Theodorus H., van der Poel, Henk G., van Leenders, Geert J.L.H., Varma, Murali, Violette, Philippe D., Wallis, Christopher J.D., Wiegel, Thomas, Wilkinson, Karen, Zattoni, Fabio, N’Dow, James M.O., Van Poppel, Hendrik, Cornford, Philip, and Mottet, Nicolas

Published
2019
Full Text
View/download PDF

22. Risk of Thrombosis and Bleeding in Gynecologic Non-Cancer Surgery: Systematic Review and Meta-Analysis

Author

Lavikainen, Lauri I., primary, Guyatt, Gordon H., additional, Kalliala, Ilkka E.J., additional, Cartwright, Rufus, additional, Luomaranta, Anna L., additional, Vernooij, Robin W.M., additional, Tähtinen, Riikka M., additional, Najafabadi, Borna Tadayon, additional, Singh, Tino, additional, Pourjamal, Negar, additional, Oksjoki, Sanna M., additional, Khamani, Nadina, additional, Karjalainen, Päivi K., additional, Joronen, Kirsi M., additional, Izett-Kay, Matthew L., additional, Haukka, Jari, additional, Halme, Alex L.E., additional, Ge, Fang Zhou, additional, Galambosi, Päivi J., additional, Devereaux, P.J., additional, Cárdenas, Jovita L., additional, Couban, Rachel J., additional, Aro, Karoliina M., additional, Aaltonen, Riikka L., additional, Tikkinen, Kari A.O., additional, Ahopelto, Kaisa, additional, Aoki, Yoshitaka, additional, Beilmann-Lehtonen, Ines, additional, Blanker, Marco H., additional, Craigie, Samantha, additional, Elberkennou, Jaana, additional, Garcia-Perdomo, Herney A., additional, Gomaa, Huda A., additional, Gross, Peter, additional, Hajebrahimi, Sakineh, additional, Huang, Linglong, additional, Karanicolas, Paul J., additional, Kilpeläinen, Tuomas P., additional, Kivelä, Antti J., additional, Korhonen, Tapio, additional, Lampela, Hanna, additional, Lee, Yung, additional, Mattila, Anne K., additional, Nykänen, Taina P., additional, Nystén, Carolina, additional, Pandanaboyana, Sanjay, additional, Ratnayake, Chathura B.B., additional, Raudasoja, Aleksi R., additional, Sallinen, Ville J., additional, Violette, Philippe D., additional, Xiao, Yingqi, additional, and Yao, Liang, additional

Published
2023
Full Text
View/download PDF

24. Update on APPEAL, an International Randomized Controlled Trial Evaluating Ciprofloxacin Versus Placebo in Patients Undergoing Shockwave Lithotripsy for Urolithiasis

Author

Gaudel, Pramila, Järvinen, Petrus, Kilpeläinen, Tuomas P., Kuutti, Pauliina, Myrskysalo, Sanna, Saalasti, Mari, Denstedt, John, Pautler, Steve, Razvi, Hassan, Tailly, Thomas, Mai Tu, Le, Lagabrielle, Samuel, Akbari, Nourieh D., Farshi Haghro, Alireza, Mohammadrahimi, Mohsen, Pourjamal, Negar, Salehi Pourmehr, Hanieh, Soleimanzadeh, Farzin, Abdulmajid, Zeenah, Al-Rumaihi, Khalid, Hussain, Salam A., Gadzhiev, Nariman, Gorelov, Dmitry, Azhar, Raed A., de Almeida Luz, Murilo, Morozov, Andrey, Hamid, Agus Rizal A.H., Tikkinen, Kari A.O., Tornberg, Sara V., Ruotsalainen, Jani, Tadayon Najafabadi, Borna, Horstia, Saana, Hajebrahimi, Sakineh, Mikkola, Arto, Abdelkareem, Mohamed, Richard, Patrick O., Bausch, Kathrin, Parpia, Sameer, Guyatt, Gordon H., and Violette, Philippe D.

Published
2024
Full Text
View/download PDF

30. 2023 UPDATE – Canadian Urological Association guideline: Management of cystic renal lesions

Author

Richard, Patrick O., primary, Violette, Philippe D., additional, Bhindi, Bimal, additional, Breau, Rodney H., additional, Gratton, Matthieu, additional, Jewett, Michael A.S., additional, Kapoor, Anil, additional, Pouliot, Frederic, additional, Leveridge, Michael, additional, So, Alan I., additional, Whelan, Tom F., additional, Rendon, Ricardo A., additional, Tanguay, Simon, additional, and Finelli, Antonio, additional

Published
2023
Full Text
View/download PDF

31. 2023 Canadian Urological Association guideline: Evaluation and management of azoospermia

Author

Flannigan, Ryan, primary, Najafabadi, Borna Tadayon, additional, Violette, Philippe D., additional, Jarvi, Keith, additional, Patel, Premal, additional, Bach, Phil Vu, additional, Domes, Trustin, additional, Zini, Armand, additional, Grober, Ethan, additional, Mak, Victor, additional, Fischer, Marc Anthony, additional, Chan, Peter, additional, Lo, Kirk, additional, Chow, Victor, additional, Wu, Chris, additional, Grantmyre, John, additional, and Patry, Genevieve, additional

Published
2023
Full Text
View/download PDF

32. Response rates in email vs. mail surveys for urologists: a randomized controlled trial

Author

Forss, Mikko, primary, Guyatt, Gordon H., additional, Bolsunovskyi, Kostiantyn, additional, Kilpeläinen, Tuomas P., additional, Lee, Yung, additional, Sairanen, Jukka, additional, Tikkinen, Kari A.O., additional, Aoki, Yoshitaka, additional, Gudjonsson, Sigurdur, additional, Hervé, François, additional, Järvinen, Petrus, additional, Malde, Sachin, additional, Miyazawa, Katsuhito, additional, Sander, Lotte, additional, Violette, Philippe D., additional, and Witte, Lambertus P.W., additional

Published
2023
Full Text
View/download PDF

34. 2023 UPDATE – Canadian Urological Association guideline: Management of cystic renal lesions: Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board

Author

Richard, Patrick O., Violette, Philippe D., Bhindi, Bimal, Breau, Rodney H., Gratton, Matthieu, Jewett, Michael A.S., Kapoor, Anil, Pouliot, Frederic, Leveridge, Michael, So, Alan I., Whelan, Tom F., Rendon, Ricardo A., Tanguay, Simon, and Finelli, Antonio

Subjects
CUA guideline
Published
2023

36. Response to Medical Assistance in Dying, Palliative Care, Safety, and Structural Vulnerability.

Author

Gallagher, Romayne, Coelho, Ramona, Violette, Philippe D., Gaind, K. Sonu, and Chochinov, Harvey Max

Subjects
ASSISTED suicide laws, HEALTH policy, SOCIAL determinants of health, ASSISTED suicide, PSYCHOLOGICAL vulnerability, SOCIOECONOMIC factors, PSYCHOLOGY of the terminally ill, PALLIATIVE treatment, PATIENT safety
Abstract

This report, signed by >170 scholars, clinicians, and researchers in palliative care and related fields, refutes the claims made by the previously published Medical Assistance in Dying, Palliative Care, Safety, and Structural Vulnerability. That report attempted to argue that structural vulnerability was not a concern in the provision of assisted dying (AD) by a selective review of evidence in medical literature and population studies. It claimed that palliative care has its own safety concerns, and that "misuse" of palliative care led to reports of wrongful death. We and our signatories do not feel that the conclusions reached are supported by the evidence provided in the contested report. The latter concluded that the logical policy response would be to address the root causes of structural vulnerability rather than restrict access to AD. Our report, endorsed by an international community of palliative care professionals, believes that public policy should aim to reduce structural vulnerability and, at the same time, respond to evidence-based cautions about AD given the potential harm. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

37. Timing of symptomatic venous thromboembolism after surgery: meta-analysis

Author

Singh, Tino, primary, Lavikainen, Lauri I, additional, Halme, Alex L E, additional, Aaltonen, Riikka, additional, Agarwal, Arnav, additional, Blanker, Marco H, additional, Bolsunovskyi, Kostiantyn, additional, Cartwright, Rufus, additional, García-Perdomo, Herney, additional, Gutschon, Rachel, additional, Lee, Yung, additional, Pourjamal, Negar, additional, Vernooij, Robin W M, additional, Violette, Philippe D, additional, Haukka, Jari, additional, Guyatt, Gordon H, additional, and Tikkinen, Kari A O, additional

Published
2023
Full Text
View/download PDF

42. 2022-RA-933-ESGO Risk of venous thromboembolism and major bleeding in gynaecological cancer surgery: series of systematic reviews and meta-analyses

Author

Lavikainen, Lauri I, primary, Guyatt, Gordon, additional, Luomaranta, Anna L, additional, Cartwrigth, Rufus, additional, Kalliala, Ilkka EJ, additional, Couban, Rachel J, additional, Aaltonen, Riikka L, additional, Aro, Karoliina M, additional, Cárdenas, Jovita L, additional, Devereaux, PJ, additional, Galambosi, Päivi J, additional, Ge, Fang Zhou, additional, Halme, Alex LE, additional, Haukka, Jari, additional, Izett-Kay, Matthew L, additional, Joronen, Kirsi M, additional, Karjalainen, Päivi K, additional, Khamani, Nadina, additional, Nystén, Carolina, additional, Oksjoki, Sanna M, additional, Pourjamal, Negar, additional, Singh, Tino, additional, Tähtinen, Riikka M, additional, Vernooij, Robin WM, additional, Violette, Philippe D, additional, and Tikkinen, Kari AO, additional

Published
2022
Full Text
View/download PDF

43. Protocol for a Series of Systematic Reviews and Network Meta-analyses of Randomized Controlled Trials of Medications for Patients with Overactive Bladder Symptoms

Author

Agarwal, Arnav, Aoki, Yoshitaka, Bauer, Scott R., Bhatnagar, Neera, Bolsunovskyi, Kostiantyn, te Brummelstroete, Gerhard H., Cárdenas, Jovita L., Cartwright, Rufus, Elterman, Dean, Eryuzlu, Leyla, Gaudel, Pramila, Gutschon, Rachel E., Griebling, Tomas L., Hallamies, Sanna K., Heikkilä, Katriina, Izhar, Zain, Kilpeläinen, Tuomas P., Khurshid, Saqib, Laakkonen, Sanna M., Lee, Yung, Lopes, Luciane C., Loohuis, Anne, Mendieta, Alexander, Mynttinen, Henri, Salehi-Pourmehr, Hanieh, Pryalukhin, Alexey, Przydacz, Mikolaj, Siddiqui, Fahad J., Tähtinen, Riikka, Vernooij, Robin W.M., Violette, Philippe D., Witte, Lambertus P.W., Yoshimura, Koji, van der Worp, Henk, Puerto Nino, Angie K., Blanker, Marco H., Brignardello-Petersen, Romina, Guyatt, Gordon H., and Tikkinen, Kari A.O.

Published
2024
Full Text
View/download PDF

44. Randomized controlled trials in de-implementation research: a systematic scoping review

Author

MS Nefrologie, Raudasoja, Aleksi J, Falkenbach, Petra, Vernooij, Robin W M, Mustonen, Jussi M J, Agarwal, Arnav, Aoki, Yoshitaka, Blanker, Marco H, Cartwright, Rufus, Garcia-Perdomo, Herney A, Kilpeläinen, Tuomas P, Lainiala, Olli, Lamberg, Tiina, Nevalainen, Olli P O, Raittio, Eero, Richard, Patrick O, Violette, Philippe D, Komulainen, Jorma, Sipilä, Raija, Tikkinen, Kari A O, MS Nefrologie, Raudasoja, Aleksi J, Falkenbach, Petra, Vernooij, Robin W M, Mustonen, Jussi M J, Agarwal, Arnav, Aoki, Yoshitaka, Blanker, Marco H, Cartwright, Rufus, Garcia-Perdomo, Herney A, Kilpeläinen, Tuomas P, Lainiala, Olli, Lamberg, Tiina, Nevalainen, Olli P O, Raittio, Eero, Richard, Patrick O, Violette, Philippe D, Komulainen, Jorma, Sipilä, Raija, and Tikkinen, Kari A O

Published
2022

47. Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy

Author

Pinthus, Jehonathan H., primary, Duivenvoorden, Wilhelmina C. M., additional, Klotz, Laurence, additional, Mukherjee, Som D., additional, Siemens, D. Robert, additional, Niazi, Tamim, additional, Fradet, Vincent, additional, Foster, William, additional, Duceppe, Emmanuelle, additional, Taussky, Daniel, additional, Hamilton, Robert, additional, Lavallée, Luke, additional, Brown, Ian, additional, Chin, Joseph, additional, Gopaul, Darin, additional, Wassef, Anthony, additional, Kassouf, Wassim, additional, Davis, Margot, additional, Violette, Philippe D., additional, Agapay, Steve, additional, Balasubramanian, Kumar, additional, Mian, Rajibul, additional, Rangarajan, Sumathy, additional, Sener, Alp, additional, Shayegan, Bobby, additional, Devereaux, P. J., additional, and Leong, Darryl P., additional

Published
2022
Full Text
View/download PDF

48. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery : systematic review and network meta-analysis of randomised trials

Author

Marcucci, Maura, Etxeandia-Ikobaltzeta, Itziar, Yang, Stephen, Germini, Federico, Gupta, Shyla, Agarwal, Arnav, Ventresca, Matthew, Tang, Shaowen, Morgano, Gian Paolo, Wang, Mengxiao, Ahmed, Muhammad Muneeb, Neumann, Ignacio, Izcovich, Ariel, Criniti, Juan, Popoff, Federico, Devereaux, P. J., Dahm, Philipp, Anderson, David, Lavikainen, Lauri, Tikkinen, Kari A. O., Guyatt, Gordon H., Schunemann, Holger J., Violette, Philippe D., Department of Surgery, Faculty of Medicine, HUS Abdominal Center, Urologian yksikkö, HYKS erva, and South Carelia Social and Health care District Eksote

Subjects
VENOUS THROMBOEMBOLISM PROPHYLAXIS, TOTAL KNEE REPLACEMENT, TOTAL HIP, ENHANCED RECOVERY, 3121 General medicine, internal medicine and other clinical medicine, MANAGEMENT, PERIOPERATIVE CARE, AMERICAN SOCIETY, PREVENTION, CANCER, HEMATOLOGY 2018 GUIDELINES
Abstract

OBJECTIVE To systematically compare the effect of direct oral anticoagulants and low molecular weight heparin for thromboprophylaxis on the benefits and harms to patients undergoing non-cardiac surgery. DESIGN Systematic review and network meta-analysis of randomised controlled trials. DATA SOURCES Medline, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL), up to August 2021. REVIEW METHODS Randomised controlled trials in adults undergoing non-cardiac surgery were selected, comparing low molecular weight heparin (prophylactic (low) or higher dose) with direct oral anticoagulants or with no active treatment. Main outcomes were symptomatic venous thromboembolism, symptomatic pulmonary embolism, and major bleeding. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used for network meta-analyses. Abstracts and full texts were screened independently in duplicate. Data were abstracted on study participants, interventions, and outcomes, and risk of bias was assessed independently in duplicate. Frequentist network meta-analysis with multivariate random effects models provided odds ratios with 95% confidence intervals, and GRADE (grading of recommendations, assessment, development, and evaluation) assessments indicated the certainty of the evidence. RESULTS 68 randomised controlled trials were included (51 orthopaedic, 10 general, four gynaecological, two thoracic, and one urological surgery), involving 45 445 patients. Low dose (odds ratio 0.33, 95% confidence interval 0.16 to 0.67) and high dose (0.19, 0.07 to 0.54) low molecular weight heparin, and direct oral anticoagulants (0.17, 0.07 to 0.41) reduced symptomatic venous thromboembolism compared with no active treatment, with absolute risk differences of 1-100 per 1000 patients, depending on baseline risks (certainty of evidence, moderate to high). None of the active agents reduced symptomatic pulmonary embolism (certainty of evidence, low to moderate). Direct oral anticoagulants and low molecular weight heparin were associated with a 2-3-fold increase in the odds of major bleeding compared with no active treatment (certainty of evidence, moderate to high), with absolute risk differences as high as 50 per 1000 in patients at high risk. Compared with low dose low molecular weight heparin, high dose low molecular weight heparin did not reduce symptomatic venous thromboembolism (0.57, 0.26 to 1.27) but increased major bleeding (1.87, 1.06 to 3.31); direct oral anticoagulants reduced symptomatic venous thromboembolism (0.53, 0.32 to 0.89) and did not increase major bleeding (1.23, 0.89 to 1.69). CONCLUSIONS Direct oral anticoagulants and low molecular weight heparin reduced venous thromboembolism compared with no active treatment but probably increased major bleeding to a similar extent. Direct oral anticoagulants probably prevent symptomatic venous thromboembolism to a greater extent than prophylactic low molecular weight heparin.

Published
2022

49. Additional file 1 of Randomized controlled trials in de-implementation research: a systematic scoping review

Author

Raudasoja, Aleksi J., Falkenbach, Petra, Vernooij, Robin W. M., Mustonen, Jussi M. J., Agarwal, Arnav, Aoki, Yoshitaka, Blanker, Marco H., Cartwright, Rufus, Garcia-Perdomo, Herney A., Kilpeläinen, Tuomas P., Lainiala, Olli, Lamberg, Tiina, Nevalainen, Olli P. O., Raittio, Eero, Richard, Patrick O., Violette, Philippe D., Komulainen, Jorma, Sipilä, Raija, and Tikkinen, Kari A. O.

Abstract

Additional file 1: eFigure1. Flow diagram. eFigure 2. Published studies per medical content area. eFigure 3. Risk of bias per question. eFigure 4. Risk of bias inside intervention categories. eFigure 5. Intervention components in single-component interventions. eMethods 1. Search strategies. eMethods 2. Risk of Bias Tool for RCTs of complex interventions. eMethods 3. Refined version of intervention taxonomy for de-implementation interventions. eMethods 4. Rationale for refined intervention taxonomy. eMethods 5. Rationale for outcome hierarchy of effectiveness outcomes in de-implementation. eMethods 6. Identified scoping and systematic reviews of de-implementation. eTable 1. Quality outcomes until 2010 and after. eTable 2. Theoretical background used in designing the interventions. eTable 3. Citations for included studies.

Published
2022
Full Text
View/download PDF

50. Additional file 2 of Randomized controlled trials in de-implementation research: a systematic scoping review

Author

Raudasoja, Aleksi J., Falkenbach, Petra, Vernooij, Robin W. M., Mustonen, Jussi M. J., Agarwal, Arnav, Aoki, Yoshitaka, Blanker, Marco H., Cartwright, Rufus, Garcia-Perdomo, Herney A., Kilpeläinen, Tuomas P., Lainiala, Olli, Lamberg, Tiina, Nevalainen, Olli P. O., Raittio, Eero, Richard, Patrick O., Violette, Philippe D., Komulainen, Jorma, Sipilä, Raija, and Tikkinen, Kari A. O.

Abstract

Additional file 2. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results